Send feedback

EBF3 p.Arg163=

c.489G>T · rs377458707 · VCV3030150

Likely benign No assertion criteria
Classification
Likely benign
ClinVar
Review
No assertion criteria ☆☆☆☆
ClinVar · 1 submitter
gnomAD v4.1
Rare
rare (popmax 0.104%, afr)
Conditions
1
EBF3-related disorder

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 0.59GERP 1.1, phastCons 1
Overall
CADD13.09PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.104% African / African-American · 78/74,800 alleles
Filtering AF 0.0856% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0787%
Overall 0.00535% 86/1,608,628 alleles · rare exomes 45/1,456,506 · genomes 41/152,122 · joint denominator
Ancestry group Frequency 1 in
African / African-Americangrpmax 0.104% 959
Remaining individualsnot grpmax-eligible 0.00644% 15,535
South Asian 0.00332% 30,125
Admixed American 0.00167% 59,896

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
EBF3
Protein
p.Arg163=
Coding
c.489G>T
MANE Select
NM_001375380
dbSNP
rs377458707
Type
single nucleotide variant
Location
chr10:129957323 (GRCh38)
Gene constraint
LOEUF 0.353 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 71.89 · 2 PDB
Residue 163
a UniProt-annotated variant site (in hadds; partial loss of transcriptional activator activity); a UniProt-annotated variant site (in hadds; loss of transcriptional activator activity); a functional site (interaction with dna)
Full EBF3 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ebf3-p-arg163 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown